Merck is on the mend (CNN Money)
In the dark autumn of 2004, when Merck withdrew its blockbuster heart drug Vioxx over concerns it caused cardiac arrest, the company lost roughly a third of its market value within days. But in 2006, Merck's shares quietly surged 40%. What's more, there may be enough upside left to this recovery to make the company a solid long-term investment again.

Edwards gets warning letter from FDA (Orange County Register)
The agency won't approve new products until the heart valve company upgrades certain quality systems.